Genomenon, Inc logo — Genomic intelligence for clinical diagnostics and precision...

Genomenon, Inc

Genomic intelligence for clinical diagnostics and precision medicine development

Founded 2014 United States Ann Arbor, United States 151 employees Series Unknown Total: $38.23M Developer Tools, Enterprise Software

General Information

Company Name Genomenon, Inc
Founded Year 2014
Location United States Ann Arbor, United States +1
Founders / Decision Makers
Team member Team member
Employees 151
Industries Developer Tools, Enterprise Software
Funding Stage Series Unknown
Social

Get notified when Genomenon, Inc moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Genomenon, Inc

Genomenon, Inc is a leading genomic intelligence company founded in 2014, with the mission to enhance patients’ lives by identifying the genomic drivers of genetic disease and cancer. Their slogan, "Genomic intelligence for clinical diagnostics and precision medicine development," encapsulates their focus. Combining AI with genomic expertise, Genomenon streamlines complex genetic data into actionable insights for patient diagnosis and precision medicine development. Their offerings span software, data, curation, and consulting services. The company's last $5.46M Venture Round investment on 16 May 2024 underscores investor confidence in its capabilities. Headquartered in the United States, Genomenon operates in the Developer Tools and Enterprise Software industries, positioning itself at the intersection of technology and healthcare.

Taxonomy: Genomics, Pharmaceuticals, Clinical Diagnostics, Software Tools, Genetic Diagnostics, Bioinformatics, Oncology, Next Generation Sequencing, DNA, Rare Diseases, Precision Medicine, Genomic Research

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 16 May 2024
Series B •••••• 10
Investor Investor Investor Investor Investor Investor Investor Investor Investor Investor
08 Mar 2022
Grant •••••• 1 •••• •••• 15 Feb 2022
Series A •••••• 9
Investor Investor Investor Investor Investor Investor Investor Investor
•••• ••••
16 Mar 2021
Seed Round •••••• 3
Investor Investor
•••• ••••
08 Jan 2019

View All 9 Funding Rounds

Genomenon, Inc Alternatives & Competitors

Genomenon, Inc vs

Make Personalized Medicine Accessible To All.

Series Unknown
121 employees
Biotechnology, Health Care
Genomenon, Inc vs

JMDNA was founded in 2012 and headquartered in Shanghai, China. It is dedicated to providing the bes...

Series B
20 employees
Biotechnology, Health Care
Genomenon, Inc vs

Leader in Genetic Testing Services, Genomics Research and Drug Discovery Solutions

Series D
1011 employees
Biotechnology, Health Care
Also compare with: Genomenon, Inc vs SeqOne SeqOne

FAQ About Genomenon, Inc

Genomic intelligence for clinical diagnostics and precision medicine development
Genomenon, Inc was founded in 2014.
Genomenon, Inc is headquartered in Ann Arbor, United States.
Genomenon, Inc operates in the following industries: Developer Tools, Enterprise Software.
Genomenon, Inc has approximately 151 employees.
Genomenon, Inc has completed 9 funding rounds, raising a total of $38.23M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Genomenon, Inc include ACT Genomics, JMDNA, MEDGENOME, DNA Link, SeqOne. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Genomenon, Inc and ACT Genomics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Genomenon, Inc and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes